Clinical pathological studies of CRC patients indicated that overexpressed H19 and downregulated miR-29-3b were both observed in the tissue samples of CRC patients with poor differentiation, advanced stages, and distant metastasis. This evidence concerns the gene H19 and colorectal carcinoma.